BTMD
biote Corp.
Overview
biote Corp is a Healthcare company operating in Medical Care Facilities with a $80.0M market cap.
BTMD missed consensus EPS by 0.2% in Q1 FY2026, reported May 11, 2026.
12 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-076 Q&A exchanges
- Q4 FY2025Earnings2026-03-113 Q&A exchanges
- Q3 FY2025Earnings2025-11-0514 Q&A exchanges
- Q2 FY2025Earnings2025-08-077 Q&A exchanges
- Q1 FY2025Earnings2025-05-0718 Q&A exchanges
- Q4 FY2024Earnings2025-03-1213 Q&A exchanges
- Q3 FY2024Earnings2024-11-1316 Q&A exchanges
- Q2 FY2024Earnings2024-08-1019 Q&A exchanges
- Q1 FY2024Earnings2024-05-0711 Q&A exchanges
- Q4 FY2023Earnings2024-03-1214 Q&A exchanges
- Q3 FY2023Earnings2023-11-086 Q&A exchanges
- Q2 FY2023Earnings2023-08-118 Q&A exchanges
History
Earnings history
- Q1 FY20262026-05-11EPS$0.08 vs $0.10-19.0%Rev$44.9M vs ——EODHD
- Q4 FY20252026-03-17EPS$0.07 vs $0.09-19.8%Rev$46.4M vs ——EODHD
- Q3 FY20252025-11-04EPS$0.22 vs $0.13+69.2%Rev$48.0M vs ——EODHD
- Q2 FY20252025-08-07EPS$0.10 vs $0.08+25.0%Rev$48.9M vs ——EODHD
- Q1 FY20252025-05-08EPS$0.37 vs $0.14+100.0%Rev$49.0M vs ——EODHD
- Q4 FY20242025-03-11EPS$0.10 vs $0.11-9.1%Rev$49.8M vs ——EODHD
- Q3 FY20242024-11-11EPS$0.33 vs $0.12+100.0%Rev$51.4M vs ——EODHD
- Q2 FY20242024-08-07EPS$-0.15 vs $0.09-100.0%Rev$49.2M vs ——EODHD
- Q1 FY20242024-05-06EPS$-0.06 vs $0.03-100.0%Rev$46.8M vs ——EODHD
- Q4 FY20232024-03-11EPS$0.18 vs $0.08+100.0%Rev$45.7M vs ——EODHD
- Q3 FY20232023-11-06EPS$0.24 vs $0.08+100.0%Rev$45.6M vs ——EODHD
- Q2 FY20232023-08-09EPS$-0.25 vs $0.10-100.0%Rev$49.3M vs ——EODHD
- Q1 FY20232023-05-08EPS$-0.39 vs $0.09-100.0%Rev$44.8M vs ——EODHD
- Q4 FY20222023-03-27EPS$0.18 vs $0.14+28.6%Rev$44.5M vs ——EODHD
- Q3 FY20222022-11-07EPS$-1.74 vs $0.14-100.0%Rev$42.0M vs ——EODHD
- Q2 FY20222022-08-08EPS$1.19 vs $0.14+100.0%Rev$41.4M vs ——EODHD
- Q1 FY20222022-05-19EPS$-0.03 vs ——Rev$37.1M vs ——EODHD
- Q4 FY20212021-12-30EPS$-0.03 vs ——Rev$37.5M vs ——EODHD
- Q3 FY20212021-11-23EPS$0.08 vs ——Rev$35.6M vs ——EODHD
- Q2 FY20212021-08-16EPS$0.23 vs ——Rev$34.8M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | 2026-05-11 | $0.08 | $0.10 | -19.0% | $44.9M | — | — | EODHD |
| Q4 FY2025 | 2026-03-17 | $0.07 | $0.09 | -19.8% | $46.4M | — | — | EODHD |
| Q3 FY2025 | 2025-11-04 | $0.22 | $0.13 | +69.2% | $48.0M | — | — | EODHD |
| Q2 FY2025 | 2025-08-07 | $0.10 | $0.08 | +25.0% | $48.9M | — | — | EODHD |
| Q1 FY2025 | 2025-05-08 | $0.37 | $0.14 | +100.0% | $49.0M | — | — | EODHD |
| Q4 FY2024 | 2025-03-11 | $0.10 | $0.11 | -9.1% | $49.8M | — | — | EODHD |
| Q3 FY2024 | 2024-11-11 | $0.33 | $0.12 | +100.0% | $51.4M | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $-0.15 | $0.09 | -100.0% | $49.2M | — | — | EODHD |
| Q1 FY2024 | 2024-05-06 | $-0.06 | $0.03 | -100.0% | $46.8M | — | — | EODHD |
| Q4 FY2023 | 2024-03-11 | $0.18 | $0.08 | +100.0% | $45.7M | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $0.24 | $0.08 | +100.0% | $45.6M | — | — | EODHD |
| Q2 FY2023 | 2023-08-09 | $-0.25 | $0.10 | -100.0% | $49.3M | — | — | EODHD |
| Q1 FY2023 | 2023-05-08 | $-0.39 | $0.09 | -100.0% | $44.8M | — | — | EODHD |
| Q4 FY2022 | 2023-03-27 | $0.18 | $0.14 | +28.6% | $44.5M | — | — | EODHD |
| Q3 FY2022 | 2022-11-07 | $-1.74 | $0.14 | -100.0% | $42.0M | — | — | EODHD |
| Q2 FY2022 | 2022-08-08 | $1.19 | $0.14 | +100.0% | $41.4M | — | — | EODHD |
| Q1 FY2022 | 2022-05-19 | $-0.03 | — | — | $37.1M | — | — | EODHD |
| Q4 FY2021 | 2021-12-30 | $-0.03 | — | — | $37.5M | — | — | EODHD |
| Q3 FY2021 | 2021-11-23 | $0.08 | — | — | $35.6M | — | — | EODHD |
| Q2 FY2021 | 2021-08-16 | $0.23 | — | — | $34.8M | — | — | EODHD |
Source: EODHD. BTMD reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks BTMD's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 9/10 quarters but stock falls 60% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 5 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.91 | $0.85 | +6.6% | -4.9% | -4.6% |
| Q4 FY2026 | $0.84 | $0.85 | -1.5% | +2.5% | +1.1% |
| Q3 FY2026 | $0.93 | $0.91 | +1.9% | +0.7% | +2.6% |
| Q2 FY2026 | $1.16 | $1.04 | +11.8% | -5.8% | -4.0% |
| Q1 FY2025 | $0.95 | $0.86 | +11.0% | +0.7% | +2.1% |
| Q4 FY2025 | $1.15 | $1.02 | +13.0% | -4.5% | -4.7% |
| Q3 FY2025 | $1.28 | $1.13 | +13.4% | +1.8% | -0.9% |
| Q2 FY2025 | $0.99 | $0.89 | +11.4% | -7.0% | -6.5% |
| Q1 FY2024 | $1.11 | $0.99 | +12.3% | -0.2% | +2.5% |
| Q4 FY2024 | $1.26 | $1.12 | +12.5% | -8.6% | -8.1% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Suspended2026-13-15
- Q3 FY2026Maintained2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Bret ChristensenCEO1 yr 4 mo6 callsCurrentSample
CEO since 2025 • 2/4 beats (50%) • last guidance raise Q3 FY2026
- Robert Charles PetersonCFO2 yr 4 mono recorded callsCurrentSample
CFO since 2024 • 5/8 beats (63%) • last guidance cut Q2 FY2026
- Daniel Michael MonicoGeneral Counsel2 mono recorded callsCurrentSample
OTHER since 2026 • 1/2 beats (50%) • last call held guidance Q1 FY2026
- Teresa Sue WeberCEO0 mono recorded callsFormerSample
CEO since 2024 • 4/8 beats (50%) • last guidance cut Q3 FY2026
- Marc D BeerExecutive Chairman0 mono recorded callsFormerSample
OTHER since 2025 • 3/4 beats (75%) • last guidance cut Q2 FY2026
- Mary Elizabeth ConlonGeneral Counsel1 yrno recorded callsFormerSample
OTHER since 2024 • 5/8 beats (63%) • last guidance cut Q1 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BTMD.
$ curl https://api.spokenalpha.com/v1/companies/BTMDFAQ
Frequently asked about BTMD
Where can I find biote Corp.'s (BTMD) earnings call transcripts?
Spoken Alpha indexes BTMD's earnings call transcripts at https://spokenalpha.com/companies/BTMD. Each call links to attributed speakers and parsed analyst Q&A.
When was biote Corp.'s most recent earnings call?
biote Corp. (BTMD) held its most recent earnings call on 2026-05-07, covering fiscal Q1 2026.
What sector is BTMD in?
biote Corp. (BTMD) operates in the Healthcare sector (Medical Care Facilities industry).